Besides the expected differences between the metabolic parameters, T2DM patients vs. healthy controls showed significant differences in relation to the hemostatic parameters, i.e., PT % activity and PAI-1, supporting the concept of a hypercoagulative, and hypofibrinolytic status in T2DM (Table 1). This evidence concerns the gene SERPINE1 and type 2 diabetes mellitus.